Evidence map›Paper›PMID 32733412›Full record

ArticleFrontiers in microbiology2020

Microscopic Investigation of the Combined Use of Antibiotics and Biosurfactants on Methicillin Resistant

Abulaziz Juma, Patrick Lemoine, Alistair B J Simpson, Jason Murray, Barry M G O'Hagan, Patrick J Naughton, James G Dooley, Ibrahim M Banat

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Rhamnolipid Micelles Assist Azithromycin in Efficiently DisruptingInternational journal of nanomedicine · 2023
    Article
  18. Review
  19. Natural Diatomite Supported Zirconium-Doped TiONanomaterials (Basel, Switzerland) · 2022
    Article
  20. Achieving Commercial Applications for Microbial Biosurfactants.Advances in biochemical engineering/biotechnology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Abulaziz JumaSchool of Biomedical Sciences, Ulster University, Coleraine, United Kingdom.
Patrick LemoineSchool of Engineering, Nanotechnology and Integrated Bioengineering Centre (NIBEC), Ulster University, Newtownabbey, United Kingdom.
Alistair B J SimpsonSchool of Engineering, Nanotechnology and Integrated Bioengineering Centre (NIBEC), Ulster University, Newtownabbey, United Kingdom.
Jason MurraySchool of Biomedical Sciences, Ulster University, Coleraine, United Kingdom.
Barry M G O'HaganSchool of Biomedical Sciences, Ulster University, Coleraine, United Kingdom.
Patrick J NaughtonSchool of Biomedical Sciences, Ulster University, Coleraine, United Kingdom.
James G DooleySchool of Biomedical Sciences, Ulster University, Coleraine, United Kingdom.
Ibrahim M BanatSchool of Biomedical Sciences, Ulster University, Coleraine, United Kingdom.
University of Ulster · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One current strategy to deal with the serious issue of antibiotic resistance is to use biosurfactants, weak antimicrobials in their own right, with antibiotics in order to extend the efficacy of antibiotics. Although an adjuvant effect has been observed, the underlying mechanisms are poorly understood. To investigate the nature of the antibiotic and biosurfactant interaction, we undertook a scanning electron microscopy (SEM) and atomic force microscopy (AFM) microscopic study of the effects of the tetracycline antibiotic, combined with sophorolipid and rhamnolipid biosurfactants, on Methicillin-resistant

Indexed as

antibioticatomic force microscopybiosurfactantscanning electron microscopyStaphylococcus aureussynergy

Identifiers

PMID32733412
PMCPMC7358407
OpenAlexW3040698312

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.